Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Improving Tuberculosis Screening in Remote Areas

02.12.2019

Every year, 1.5 million people die from tuberculosis (TB) worldwide. Diagnosis and treatment is particularly difficult in remote rural areas. Today, the Swiss Tropical and Public Health Institute (Swiss TPH) together with international partners announce the launch of the 4-year TB TRIAGE+ project after signing a grant agreement with the European and Developing Countries Clinical Trials Partnership (EDCTP). TB TRIAGE+ will evaluate new diagnostic approaches to make active TB case finding more efficient and cost-effective in remote areas of southern Africa.

Tuberculosis (TB) is the number one infectious disease killer worldwide. Particularly in hard-to-reach populations, diagnosis and treatment of TB remains very challenging. In high-burden areas, one third of patients are never diagnosed.


Finding and testing tuberculosis patients in remote areas can be challenging.

Photo: Niklaus Labhardt/Swiss TPH

To find, diagnose and treat these patients, several countries have adopted active TB case finding campaigns. During such campaigns, people are asked about symptoms suggestive of TB and, if positive, will be tested with a molecular sputum test, the Xpert MTB/RIF.

“Testing everyone with Xpert MTB/RIF who presents with unspecific TB symptoms is labour intensive and costly, considering that the majority of people do not actually have TB,” said Klaus Reither, Head of the Clinical Research Unit at Swiss TPH and project leader of TB TRIAGE+.

“A much more efficient and cost-effective method would be to do a triage test first to exclude people who are very unlikely to have TB. The molecular test would then only need to be performed on those with a high probability.”

The TB TRIAGE+ project will assess the accuracy, impact and cost-effectiveness of novel active TB case finding strategies at a community level, which will help to triage potential TB patients. The centerpiece of TB TRIAGE+ is a large-scale cluster-randomized clinical trial in rural communities of Lesotho and KwaZulu-Natal in South Africa, which are areas heavily affected by both the TB and HIV epidemics. TB TRIAGE+ is funded by EDCTP with EUR 3.19 million and starts on 1 January 2020.

Novel x-ray analysis and blood marker to triage patients

“The aim of the main trial of TB TRIAGE+, which will includes 35,000 people, is to identify a suitable triage strategy which improves early access to diagnosis and treatment and will substantially reduce diagnostic costs,” said Reither.

On the one hand, the project will test the automated chest x-ray analysis platform (CAD4TB), which can tell within seconds whether there is evidence of pulmonary TB. “CAD4TB has become a high-throughput screening tool, meaning that many people can be screened for TB in a short period of time.

In combination with a portable x-ray machine, we will perform and analyse chest radiographs even in the most remote settings,” said Reither. On the other hand, the C-reactive protein test, a well-known blood marker for inflammation and infection, will be tested for its potential as a point-of-care TB triage test. In the trial, both approaches will be compared to the current standard of care.

About TB TRIAGE+

Apart from the large community trial, TB TRIAGE+ also intends to answer a range of research questions linked to triage testing and active TB case finding. The project will also build research capacity and new networks for future research.

Swiss TPH leads TB TRIAGE+ in partnership with SolidarMed (Lesotho/Switzerland), the Human Sciences Research Council (South Africa), the Institute of Tropical Medicine in Antwerp (Belgium), the Radboud University Medical Center, Nijmegen (Netherlands), the Charité Universitätsmedizin Berlin (Germany) and University Hospital of Basel (Switzerland).

Wissenschaftliche Ansprechpartner:

Klaus Reither, Head of the Clinical Research Unit at Swiss TPH and project leader of TB TRIAGE+, Tel. 061 284 89 67, klaus.reither@swisstph.ch

Weitere Informationen:

https://www.swisstph.ch/en/news/news-detail/news/improving-tuberculosis-screenin...

Sabina Beatrice-Matter | idw - Informationsdienst Wissenschaft
Further information:
https://www.swisstph.ch

Further reports about: C-reactive protein TB TuBerculosis blood marker x-ray analysis

More articles from Health and Medicine:

nachricht UTMB researchers have discovered a new antiviral mechanism for dengue therapeutics
14.07.2020 | University of Texas Medical Branch at Galveston

nachricht Scientists use nanoparticle-delivered gene therapy to inhibit blinding eye disease in rodents
08.07.2020 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A new path for electron optics in solid-state systems

A novel mechanism for electron optics in two-dimensional solid-state systems opens up a route to engineering quantum-optical phenomena in a variety of materials

Electrons can interfere in the same manner as water, acoustical or light waves do. When exploited in solid-state materials, such effects promise novel...

Im Focus: Electron cryo-microscopy: Using inexpensive technology to produce high-resolution images

Biochemists at Martin Luther University Halle-Wittenberg (MLU) have used a standard electron cryo-microscope to achieve surprisingly good images that are on par with those taken by far more sophisticated equipment. They have succeeded in determining the structure of ferritin almost at the atomic level. Their results were published in the journal "PLOS ONE".

Electron cryo-microscopy has become increasingly important in recent years, especially in shedding light on protein structures. The developers of the new...

Im Focus: The spin state story: Observation of the quantum spin liquid state in novel material

New insight into the spin behavior in an exotic state of matter puts us closer to next-generation spintronic devices

Aside from the deep understanding of the natural world that quantum physics theory offers, scientists worldwide are working tirelessly to bring forth a...

Im Focus: Excitation of robust materials

Kiel physics team observed extremely fast electronic changes in real time in a special material class

In physics, they are currently the subject of intensive research; in electronics, they could enable completely new functions. So-called topological materials...

Im Focus: Electrons in the fast lane

Solar cells based on perovskite compounds could soon make electricity generation from sunlight even more efficient and cheaper. The laboratory efficiency of these perovskite solar cells already exceeds that of the well-known silicon solar cells. An international team led by Stefan Weber from the Max Planck Institute for Polymer Research (MPI-P) in Mainz has found microscopic structures in perovskite crystals that can guide the charge transport in the solar cell. Clever alignment of these "electron highways" could make perovskite solar cells even more powerful.

Solar cells convert sunlight into electricity. During this process, the electrons of the material inside the cell absorb the energy of the light....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Contact Tracing Apps against COVID-19: German National Academy Leopoldina hosts international virtual panel discussion

07.07.2020 | Event News

International conference QuApps shows status quo of quantum technology

02.07.2020 | Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

 
Latest News

Nanoelectronics learn the same way as the human brain

15.07.2020 | Information Technology

Mobile EEG for the detection of epileptic seizures in daily life

15.07.2020 | Medical Engineering

When Concrete learns to pre-stress itself

15.07.2020 | Architecture and Construction

VideoLinks
Science & Research
Overview of more VideoLinks >>>